Pandion Therapeutics Inc (PAND) Stock Analyst Ratings
NASDAQ:PAND - Nasdaq -
ChartMill assigns a Buy % Consensus number of 73% to PAND. The Buy consensus is the weighted average rating of the current analysts ratings.
PAND was analyzed by 3 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about PAND.
In the previous month the buy percentage consensus was at a similar level.
Only 3 analysts analyzed PAND. So this is just the average opinion of a couple of analysts.